HAVN Financial Statements From 2010 to 2024
| HAVLF Stock | USD 0.01 0.0002 4.00% |
Check HAVN Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HAVN Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . HAVN financial statements analysis is a perfect complement when working with HAVN Life Valuation or Volatility modules.
HAVN |
HAVN Life Sciences Company Operating Margin Analysis
HAVN Life's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current HAVN Life Operating Margin | (7.64) % |
Most of HAVN Life's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HAVN Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, HAVN Life Sciences has an Operating Margin of -7.6356%. This is 78.23% lower than that of the Healthcare sector and 93.19% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 38.58% higher than that of the company.
HAVN Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HAVN Life's current stock value. Our valuation model uses many indicators to compare HAVN Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HAVN Life competition to find correlations between indicators driving HAVN Life's intrinsic value. More Info.HAVN Life Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HAVN Life's earnings, one of the primary drivers of an investment's value.About HAVN Life Financial Statements
HAVN Life stakeholders use historical fundamental indicators, such as HAVN Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although HAVN Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in HAVN Life's assets and liabilities are reflected in the revenues and expenses on HAVN Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in HAVN Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was incorporated in 2020 and is headquartered in Richmond, Canada. Havn Life operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in HAVN Pink Sheet
HAVN Life financial ratios help investors to determine whether HAVN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HAVN with respect to the benefits of owning HAVN Life security.